We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Images Identified for Breast Cancer Cell Histopathology

By LabMedica International staff writers
Posted on 11 Nov 2016
Print article
Image: Photomicrographs of a) Lymphocytes, b) Normal epithelial nuclei, c) Cancerous epithelial nuclei, and d) Mitotic nuclei (Photo courtesy of Trinity College Dublin).
Image: Photomicrographs of a) Lymphocytes, b) Normal epithelial nuclei, c) Cancerous epithelial nuclei, and d) Mitotic nuclei (Photo courtesy of Trinity College Dublin).
Breast cancer is the most prevalent form of cancer for women worldwide. Current breast cancer clinical practice and treatment mainly relies on the evaluation of the disease's prognosis using the Bloom-Richardson grading system.

The advent of digital pathology and fast digital slide scanners has opened the possibility of automating the prognosis by applying image-processing methods and while this undoubtedly represents progress, image-processing methods have struggled to analyze high-grade breast cancer cells as these cells are often clustered together and have vague boundaries, which make successful detection extremely challenging.

An international team comprising engineers, mathematicians and doctors led by those at Trinity College Dublin (Ireland) have has applied a technique used for detecting damage in underwater marine structures to identify cancerous cells in breast cancer histopathology images. The team has proposed a novel segmentation algorithm for detecting individual nuclei from hematoxylin and eosin (H&E) stained breast histopathology images. This detection framework estimates a nuclei saliency map using tensor voting followed by boundary extraction of the nuclei on the saliency map using a Loopy Back Propagation (LBP) algorithm on a Markov Random Field (MRF).

The method was tested on both whole-slide images and frames of breast cancer histopathology images. The investigators considered the likelihood of every point in a histopathology image either being near a cell center or a cell boundary and using a belief propagation algorithm, the most suitable cell boundaries were then traced out. Test results show that the proposed method is suitable for nuclei segmentation in high-grade breast cancer histopathology images containing scenes depicting grade 3 nuclear pleomorphism (cancerous nuclei with marked variations from normal nuclei) even though these are quite challenging for traditional segmentation methods to detect.

Maqlin Paramanandam, PhD, the lead author of the study said, “The potential for this technology is very exciting and we are delighted that this international and inter-disciplinary team has worked so well at tackling a real bottle-neck in automating the diagnosis of breast cancer using histopathology images.” The study was published on September 20, 2016, in the journal Public Library of Science ONE.

Related Links:
Trinity College Dublin

New
Gold Member
Rotavirus Test
Rotavirus Test - 30003 – 30073
Verification Panels for Assay Development & QC
Seroconversion Panels
New
H.pylori Test
Humasis H.pylori Card
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED

Print article

Channels

Molecular Diagnostics

view channel
Image: The experimental blood test accurately indicates severity and predicts potential recovery from spinal cord injury (Photo courtesy of 123RF)

Blood Test Identifies Multiple Biomarkers for Rapid Diagnosis of Spinal Cord Injury

The National Institutes of Health estimates that 18,000 individuals in the United States sustain spinal cord injuries (SCIs) annually, resulting in a staggering financial burden of over USD 9.... Read more

Immunology

view channel
Image: The findings were based on patients from the ADAURA clinical trial of the targeted therapy osimertinib for patients with NSCLC with EGFR-activated mutations (Photo courtesy of YSM Multimedia Team)

Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions

In the ongoing advancement of personalized medicine, a new study has provided evidence supporting the use of a tool that detects cancer-derived molecules in the blood of lung cancer patients years after... Read more

Microbiology

view channel
Image: Schematic representation illustrating the key findings of the study (Photo courtesy of UNIST)

Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours

Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more

Industry

view channel
Image: Tumor-associated macrophages visualized using the Multiomic LS Assay (Photo courtesy of ACD)

Leica Biosystems and Bio-Techne Expand Spatial Multiomic Collaboration

Bio-Techne Corporation (Minneapolis, MN, USA) has expanded the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD, Newark, CA, USA), and Leica Biosystems (Nussloch,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.